高龄患者置入无导线起搏器的可行性与安全性分析
本研究为回顾性队列研究,纳入2020年1月至2023年12月在北京大学人民医院和河南省人民医院行无导线起搏器置入的140例患者,按年龄分为非高龄组(<75岁,64例)和高龄组(≥75岁,76例)。结果显示两组术中及术后24小时、3个月、6个月起搏参数差异均无统计学意义,高龄组仅1例(0.7%)发生心包填塞经引流好转,无起搏器相关并发症,提示高龄患者置入无导线起搏器可行且安全有效。
要点
- 高龄组(≥75岁)置入无导线起搏器成功,术中起搏参数与非高龄组无显著差异。
- 高龄组术中仅1例(0.7%)发生心包填塞,经穿刺引流后好转。
- 术后6个月内两组起搏阈值、感知、阻抗无显著差异,无起搏器相关并发症。
核心结论
- 高龄患者(≥75岁)置入无导线起搏器方法可行且安全有效。
研究设计与样本
- 回顾性队列研究,连续纳入2020年1月至2023年12月北京大学人民医院和河南省人民医院行无导线起搏器置入的140例患者。
- 按年龄分为非高龄组(<75岁,64例)和高龄组(≥75岁,76例)。
主要发现
- 高龄组体重指数较低,心房颤动/心房扑动、高血压、冠心病、卒中合并症比例较高,瓣膜疾病术后比例较低(P均<0.05)。
- 高龄组首次置入无导线起搏器比例较高[48.7%(37/76)比21.9%(14/64),P=0.001],传统起搏器导线拔除后改置入无导线起搏器的原因中囊袋感染占比较低[43.4%(33/76)比65.6%(42/64),P=0.006]。
- 两组无导线起搏器置入时起搏参数差异无统计学意义(P均>0.05)。
- 所有患者成功置入,高龄组1例(0.7%)术中发生心包填塞,经穿刺引流后好转。
- 术后24小时、3个月、6个月随访,两组起搏阈值、感知、阻抗差异均无统计学意义(P均>0.05),无起搏器相关并发症。
临床怎么用
- 对于≥75岁高龄患者,无导线起搏器置入可作为可行且安全有效的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives: To analyze the feasibility and safety of leadless pacemakers in elderly patients. Methods: This retrospective cohort study analyzed 140 patients who underwent leadless pacemaker implantation at People's Hospital of Peking University and People's Hospital of Henan Province between January 2020 and December 2023. The patients were categorized into a non-elderly group (age<75 years) and an elderly group (age≥75 years). The study compared and analyzed demographic information, clinical data, pacing parameters during the surgery and surgery-related complications between the two groups. Pacing parameters (threshold, sensing, and impedance) were monitored in both groups at 24 hours, 3 months, and 6 months post-procedure, and pacing-related complications were recorded. Results: A total of 140 patients were enrolled, with a mean age of (73.6±13.2) years, including 83 males (59.3%). There were 64 patients in the non-elderly group and 76 patients in the elderly group. Compared to the non-elderly group, the elderly group had a lower body mass index, a higher proportion of comorbidities such as atrial fibrillation/atrial flutter, hypertension, coronary heart disease, and stroke, and a lower proportion of postoperative valvular diseases (all P<0.05). The elderly group had a higher proportion of patients undergoing leadless pacemaker implantation for the first time (48.7% (37/76) vs. 21.9% (14/64), P=0.001) and a lower rate of leadless pacemaker re-implantation after infection and lead removal (43.4% (33/76) vs. 65.6% (42/64), P=0.006) than the non-elderly group. There were no significant differences in pacing parameters at the time of leadless pacemaker implantation between the two groups (all P>0.05). All patients were successfully implanted with a leadless pacemaker, with only 1 case (0.7%) in the elderly group experiencing pericardial tamponade, which was resolved through puncture and drainage. Additionally, no notable disparities in pacing threshold, sensing, and impedance were observed during the 24-hour, 3-month, and 6-month follow-up periods between the two groups (all P>0.05), and no pacemaker-related complications were observed. Conclusion: Implantation of a leadless pacemaker device in elderly patients (age≥75 years) is safe and effective. 目的: 分析无导线起搏器在高龄患者中的可行性和安全性。 方法: 本研究为回顾性队列研究,连续纳入2020年1月至2023年12月在北京大学人民医院和河南省人民医院行无导线起搏器置入的患者,根据年龄分为非高龄组(<75岁)和高龄组(≥75岁)。分析两组患者的一般资料和临床资料,对比分析两组术中起搏参数和手术相关并发症,随访记录术后24 h、3个月、6个月两组的起搏参数(阈值、感知、阻抗),评估有无起搏相关的并发症。 结果: 共纳入140例患者,年龄(73.6±13.2)岁,男性83例(59.3%),非高龄组64例,高龄组76例。与非高龄组相比,高龄组患者体重指数较低,心房颤动/心房扑动、高血压、冠心病、卒中合并症比例较高,瓣膜疾病术后的比例较低(P均<0.05);高龄组患者是首次置入无导线起搏器的比例较高[48.7%(37/76)比21.9%(14/64),P=0.001],传统起搏器导线拔除后改置入无导线起搏器的原因中,囊袋感染占比较低[43.4%(33/76)比65.6%(42/64),P=0.006]。两组患者无导线起搏器置入时起搏参数差异无统计学意义(P均>0.05)。所有患者成功置入无导线起搏器,1例(0.7%)高龄组患者术中发生心包填塞,经穿刺引流后好转。术后随访期间,两组起搏阈值、感知、阻抗差异均无统计学意义(P均>0.05),无起搏器相关的并发症发生。 结论: 高龄患者(≥75岁)置入无导线起搏器方法可行且安全有效。.
引用
- Wang JJ, Ze F, Li XB, et al. [Feasibility and safety of leadless pacemaker implantation in elderly patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42161626. doi:10.3760/cma.j.cn112148-20260305-00138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。